Published in Cancer Weekly, February 10th, 2009
"Biopsy results were classified as diagnostic ( malignant or benign) or nondiagnostic. Sensitivity, specificity, and negative predictive value ( NPV) were calculated for all patients, and the Fisher-Freeman-Halton exact test was used to determine whether test characteristics varied by patient history ( presence of a known cancer), mass size (< 4 cm vs >=...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.